Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.